EVAXION
LIVE

Serial Number

79342587

Owner

EVAXION BIOTECH A/S

Attorney

Michael R. Rizzo

Filing Date

Feb 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EVAXION Trademark

Serial Number: 79342587 • Registration: 7147508

EVAXION is a trademark filed by EVAXION BIOTECH A/S on February 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EVAXION BIOTECH A/S

Dr Neergaards Vej 5F

Entity Type: 65

Evaxion A/S

Dr Neergaards Vej 5F

Entity Type: 98

Trademark Details

Filing Date

February 10, 2022

Registration Date

August 29, 2023

Published for Opposition

June 13, 2023

Goods & Services

Pharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; biopharmaceuticals for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; immunotherapy preparations for treating cancer and infectious diseases; monoclonal antibodies (mAb) for medical purposes; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use

Scientific and technological research services in the field of oncology, infectious diseases, and immunology; scientific research and development services in the fields of immunology and oncology; decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; clinical medical research in the field of oncology, infectious diseases, and immunology; research and development of vaccines and medicines; scientific and technological research relating to virus, oncology, and autoimmune diseases; scientific and technological research relating to allergies

Downloadable software for design of pharmaceuticals; downloadable artificial intelligence software for design of pharmaceuticals; downloadable artificial intelligence and machine learning software for design of pharmaceuticals; downloadable artificial intelligence software platforms for design of pharmaceuticals; downloadable software for evaluating medical treatment options and treatment outcomes for cancer; downloadable software for design and development of immunotherapy; downloadable software and downloadable artificial intelligence software for identifying antigens and epitopes; downloadable software and downloadable artificial intelligence software for designing and developing vaccines and medicines; downloadable software and downloadable artificial intelligence software for designing pharmaceuticals for cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 19, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2025 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 1, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 1, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2023 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 29, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 29, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 29, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Jun 13, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 13, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 13, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 24, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 24, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2023 CNSA
ASSIGNED TO EXAMINER
May 10, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 30, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 29, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 26, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Sep 18, 2022 NREP
APPLICATION FILING RECEIPT MAILED
Jun 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 16, 2022 REPR